Satoreotide [CAS 1801415-23-5]

Satoreotide (JR11) is a SSTR2 antagonist. Satoreotide is usually conjugated with radiolabeled chelators used in neuroendocrine tumor imaing[1].

[1801415-23-5]

C58H72ClN15O14S2

1302.87

O=C([C@@H](NC([C@@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@@H](C(N)=O)CC2=CC=C(C=C2)O)=O)NC([C@@H](N)CC3=CC=C(C=C3)Cl)=O)=O)CC4=CC=C(C=C4)NC([C@@H]5CC(NC(N5)=O)=O)=O)N[C@@H]1CC6=CC=C(C=C6)NC(N)=O

Radionuclide-Drug Conjugates (RDCs) ; Somatostatin Receptor

SSTR2

98.88

DMSO : 100 mg/mL (ultrasonic)

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice